Thursday, October 15, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· March 10, 2026

Stock market today: Dow, S&P 500, Nasdaq climb, oil tanks as Wall Street weighs Iran war signals

View original at finance.yahoo.com
Stock market today: Dow, S&P 500, Nasdaq climb, oil tanks as Wall Street weighs Iran war signals US stocks turned green on Tuesday as investors weighed President Trump's hint at a swift end to the Iran war, while oil futures tumbled as much as 15%…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The US hasn't won enough and will not allow a terrorist regime to hold the world hostage and attempt to stop the globe's oil supply

    80% confidence
  • If the Strait is not reopened soon, the consequences will be catastrophic for the global economy

    80% confidence
  • The stocks that have been leading were the leaders Monday — a return to form, some might say

    80% confidence
  • The US-Israel offensive has effectively cut off Iran's naval and air capabilities, and is very far ahead of an expected four-to-five week timeline

    80% confidence
  • The Iran war is the biggest crisis the region's oil and gas industry has faced

    80% confidence
  • IEA member governments will assess current security of supply and market conditions to inform a subsequent decision on whether to make emergency stocks available

    80% confidence
  • The Middle East is a concentrated source of supply through the Strait of Hormuz, and Exxon is focused on ensuring people operating JVs have been safely evacuated and operations continue running

    80% confidence
  • The offensive is not done yet

    80% confidence
  • Compared to 2022, the labor market isn't as hot, inflation isn't as high, and fiscal support isn't as large, setting up a more dovish Fed response if the oil shock is persistent

    80% confidence
  • G7 countries want to be ready to release barrels from their strategic petroleum reserves

    80% confidence
  • Demand for HPE products and solutions was strong, with orders increasing double digits year over year across all segments

    80% confidence
  • The war is very complete, pretty much

    80% confidence
  • Expecting a hawkish response from the Fed to rising oil prices could be a mistake. Supply shocks create risks to both sides of the Fed's dual mandate

    80% confidence
  • The war with Iran could be over very soon

    80% confidence
  • Saudi Aramco can ramp up oil production in days and not weeks

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com